Literature DB >> 6600468

CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice.

B Golding, H Golding, P G Foiles, J I Morton.   

Abstract

BXSB male mice spontaneously develop progressive autoimmune disease characterized by high serum immunoglobulins, including anti-nuclear antibodies (ANA), enlarged spleen and lymph nodes, and diffuse proliferative glomerulonephritis. Females develop symptoms at a much slower rate. The mechanisms underlying the autoimmune disease and the nature of the Y-linked accelerating factor have not yet been elucidated. We found that the male progeny of the cross between the non-autoimmune strain CBA/Ca and BXSB (CBA/Ca X BXSB)F1 showed progressing signs of autoimmunity starting at 6 to 7 mo. In contrast, the male progeny that resulted from BXSB males crossed with immune-defective CBA/N females (Xid) were devoid of splenic B colonies, were nonresponsive to TNP-Ficoll, and were free of autoimmune disease for at least 10 mo. At 18 mo, some of the (CBA/N X BXSB)F1 mice developed weak antinuclear antibodies, but no spleen or lymph node enlargement was seen. The same mice had low anti-TNP Ficoll responses but did not produce B colonies in vitro. The role of the X chromosome in regulating expression of autoimmunity in young and old BXSB mice is discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6600468

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Genes on the X chromosome affect development of collagen-induced arthritis in mice.

Authors:  L Jansson; R Holmdahl
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

2.  Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.

Authors:  Kristina E Halcomb; Sandirai Musuka; Toni Gutierrez; Heather L Wright; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

3.  Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production.

Authors:  Nicole J Horwood; Tara Mahon; John P McDaid; Jamie Campbell; Hiroyuki Mano; Fionula M Brennan; David Webster; Brian M J Foxwell
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.